These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8129479)

  • 1. Time and change: new dimensions in the immunopathologic spectrum of leprosy.
    Scollard DM
    Ann Soc Belg Med Trop; 1993; 73 Suppl 1():5-11. PubMed ID: 8129479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inside the skin: the local immune and inflammatory milieu in leprosy.
    Scollard DM
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of leprosy skin lesions.
    Rea TH; Modlin RL
    Semin Dermatol; 1991 Sep; 10(3):188-93. PubMed ID: 1931567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic characteristics of leprosy reactions.
    Scollard DM; Smith T; Bhoopat L; Theetranont C; Rangdaeng S; Morens DM
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):559-67. PubMed ID: 7868954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognizing and managing the immunologic reactions in leprosy.
    Kamath S; Vaccaro SA; Rea TH; Ochoa MT
    J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral zinc supplementation on the cell mediated immunity in lepromatous leprosy.
    el-Shafei MM; Kamal AA; Soliman H; el Shayeb F; Abdel Baqui MS; Faragalla S; Sabry MK
    J Egypt Public Health Assoc; 1988; 63(5-6):311-36. PubMed ID: 2979949
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cell mediated immune response in leprosy lesions].
    Fujita M; Miyachi Y; Izumi S; Imamura S
    Nihon Rai Gakkai Zasshi; 1989; 58(2):85-91. PubMed ID: 2697713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.
    Sunderkötter CH; Tomimori-Yamashita J; Nix V; Maeda SM; Sindrilaru A; Mariano M; Sorg C; Roth J
    Immunology; 2004 Apr; 111(4):472-80. PubMed ID: 15056385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
    Rada EM; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.
    Inkeles MS; Teles RM; Pouldar D; Andrade PR; Madigan CA; Lopez D; Ambrose M; Noursadeghi M; Sarno EN; Rea TH; Ochoa MT; Iruela-Arispe ML; Swindell WR; Ottenhoff TH; Geluk A; Bloom BR; Pellegrini M; Modlin RL
    JCI Insight; 2016 Sep; 1(15):e88843. PubMed ID: 27699251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of the 5' flanking region of the IL-12 receptor beta2 gene partially determines the clinical types of leprosy through impaired transcriptional activity.
    Ohyama H; Ogata K; Takeuchi K; Namisato M; Fukutomi Y; Nishimura F; Naruishi H; Ohira T; Hashimoto K; Liu T; Suzuki M; Uemura Y; Matsushita S
    J Clin Pathol; 2005 Jul; 58(7):740-3. PubMed ID: 15976343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema nodosum leprosum: reactional leprosy.
    Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
    Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
    Corbeau P; Desforges S; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
    [No Abstract]   [Full Text] [Related]  

  • 20. Leprosy reactions. New knowledge.
    Naafs B
    Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.